Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Could This Move by Moderna Cost Pfizer Billions?

TheMotleyFool 
0 0 28.08.22
Could This Move by Moderna Cost Pfizer Billions?: https://investors.biontech.de/media-materials
 

Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) just may be the most talked-about companies on the planet. That's because this big pharma-biotech team brought the very first coronavirus vaccine to market -- and went on to generate billions from the product.

Rival Moderna's (NASDAQ: MRNA) coronavirus vaccine has been bringing in billions of dollars, too. That product launched only a few weeks after the Pfizer-BioNTech vaccine; both vaccines clearly won the vaccine race. Today, though, Moderna says its own research has a lot to do with its rivals' success. Moderna is suing Pfizer and BioNTech for patent infringement. Could this move cost Pfizer billions?

First, a look at both vaccines. The Moderna and Pfizer vaccines are based on mRNA technology. The idea is to use messenger RNA to instruct the body to produce a copy of the coronavirus spike protein. This spurs an immune system response.

Continue reading


Source Fool.com

Like: 0
PFE
Share

Comments

Not a member yet? Sign up for free!